Plus, news about Harbour BioMed, Omeros, Gilead, Repare Therapeutics, Vaccinex and Foresee Pharmaceuticals.
💵 ASK Pharm nabs China rights to pan-RAS inhibitor: ASK Pharm, also known as Jiangsu Aosaikang Pharmaceutical, will
↧